Methods for the early diagnosis of ovarian cancer
AssigneeBoard of Trustees of the University of Arkansas
InventorsTimothy J. O'Brien, Martin J. Cannon, Alessandro Santin
Life of this patent
Estimating the term…
Abstract
The disclosed nucleic acid primer sets, used in combination with quantitative amplification (PCR) of tissue cDNA, can indicate the presence of specific proteases in a tissue sample. Specifically, the present invention relates to expression of hepsin protease. The detected proteases are themselves specifically overexpressed in certain cancers, and the presence of their genetic precursors may serve for early detection of associated ovarian and other malignancies, and for the design of interactive therapies for cancer treatment.
Claims2
A method of producing activated T cells directed toward hepsin, comprising the steps of:
- exposing dendritic cells to a hepsin fragment consisting of the amino acid sequence of SEQ ID NO. 28 or 148, thereby producing activated dendritic cells;
- exposing said activated dendritic cells to T cells, wherein said activated dendritic cells would present said hepsin fragment to said T cells, thereby producing activated T cells directed toward said hepsin fragment.
Dependencies are inferred from the claim text.